Hancock Whitney’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
Hancock Whitney's BMRN Position: Q3 2026 in Review
Hancock Whitney opened a new position in BioMarin Pharmaceuticals (BMRN) in Q3 2026: 120,045 shares worth $7.2M. The stake represents 0.13% of the portfolio and ranks #150 among its holdings. This is a return to the name: Hancock Whitney previously reported a position in BMRN as recently as Q1 2024.
Hancock Whitney first reported a position in BMRN in Q3 2018 and has held it in 23 quarters since. 567 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- Hancock Whitney held 120,045 shares of BioMarin Pharmaceuticals worth $7.2M as of Q3 2026.
- BioMarin Pharmaceuticals was a new Hancock Whitney position in Q3 2026.
- BioMarin Pharmaceuticals made up 0.13% of Hancock Whitney's portfolio in Q3 2026, its #150 holding.
- Hancock Whitney first reported a position in BioMarin Pharmaceuticals in Q3 2018 and has held it in 23 quarters since.
- 567 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on Hancock Whitney's 13F filing for Q3 2026, filed 16 Nov 2026.